Adage capital partners gp llc - see foonote investment history in Five prime therapeutics inc

Filed on 2015-10-19 by Adage Capital Partners Gp Llc SEC CIK 1165408 Form 4

Accession 0000902664-15-003962.txt Sec File: edgar/data/1165408/0000902664-15-003962-index.htm

2015-10-15 Adage Capital Partners Gp Llc (CIK 1165408) through See Foonote

Invested in Five Prime Therapeutics Inc sold 25000 shares at $27.00 remaining shares owned 2539949

Common Stock Five Prime Therapeutics Inc Fprx Transaction code: S Open market or private sale of securities

f1 the securities to which this filing relates are held directly by adage capital partners, l.p., a delaware limited partnership (the "fund"). adage capital partners gp, l.l.c., a delaware limited liability company ("acpgp"), serves as the general partner of the fund and as such has discretion over the portfolio securities beneficially owned by the fund. adage capital advisors, l.l.c., a delaware limited liability company ("aca"), is the managing member of acpgp and directs acpgp's operations. robert atchinson and phillip gross are the managing members of acpgp and aca and general partners of the fund. acpgp, aca, robert atchinson and phillip gross disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.


Filed on 2015-10-19 by Adage Capital Partners Gp Llc SEC CIK 1165408 Form 4

Accession 0000902664-15-003962.txt Sec File: edgar/data/1165408/0000902664-15-003962-index.htm

2015-10-15 Adage Capital Partners Gp Llc (CIK 1165408) through See Foonote

Invested in Five Prime Therapeutics Inc sold 25000 shares at $28.85 remaining shares owned 2564949

Common Stock Five Prime Therapeutics Inc Fprx Transaction code: S Open market or private sale of securities

f1 the securities to which this filing relates are held directly by adage capital partners, l.p., a delaware limited partnership (the "fund"). adage capital partners gp, l.l.c., a delaware limited liability company ("acpgp"), serves as the general partner of the fund and as such has discretion over the portfolio securities beneficially owned by the fund. adage capital advisors, l.l.c., a delaware limited liability company ("aca"), is the managing member of acpgp and directs acpgp's operations. robert atchinson and phillip gross are the managing members of acpgp and aca and general partners of the fund. acpgp, aca, robert atchinson and phillip gross disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.


Filed on 2015-10-19 by Adage Capital Partners Gp Llc SEC CIK 1165408 Form 4

Accession 0000902664-15-003962.txt Sec File: edgar/data/1165408/0000902664-15-003962-index.htm

2015-10-15 Adage Capital Partners Gp Llc (CIK 1165408) through See Foonote

Invested in Five Prime Therapeutics Inc sold 65687 shares at $27.58 remaining shares owned 2589949

Common Stock Five Prime Therapeutics Inc Fprx Transaction code: S Open market or private sale of securities

f1 the securities to which this filing relates are held directly by adage capital partners, l.p., a delaware limited partnership (the "fund"). adage capital partners gp, l.l.c., a delaware limited liability company ("acpgp"), serves as the general partner of the fund and as such has discretion over the portfolio securities beneficially owned by the fund. adage capital advisors, l.l.c., a delaware limited liability company ("aca"), is the managing member of acpgp and directs acpgp's operations. robert atchinson and phillip gross are the managing members of acpgp and aca and general partners of the fund. acpgp, aca, robert atchinson and phillip gross disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.


Filed on 2015-10-19 by Adage Capital Partners Gp Llc SEC CIK 1165408 Form 4

Accession 0000902664-15-003962.txt Sec File: edgar/data/1165408/0000902664-15-003962-index.htm

2015-10-15 Adage Capital Partners Gp Llc (CIK 1165408) through See Foonote

Invested in Five Prime Therapeutics Inc sold 9313 shares at $28.02 remaining shares owned 2655636

Common Stock Par Value 0001 Common Stock Five Prime Therapeutics Inc Fprx Transaction code: S Open market or private sale of securities

f1 the securities to which this filing relates are held directly by adage capital partners, l.p., a delaware limited partnership (the "fund"). adage capital partners gp, l.l.c., a delaware limited liability company ("acpgp"), serves as the general partner of the fund and as such has discretion over the portfolio securities beneficially owned by the fund. adage capital advisors, l.l.c., a delaware limited liability company ("aca"), is the managing member of acpgp and directs acpgp's operations. robert atchinson and phillip gross are the managing members of acpgp and aca and general partners of the fund. acpgp, aca, robert atchinson and phillip gross disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.